Corinne Le Goff

Chief Commercial Officer · Viatris

Pharmaceuticals

Corinne Le Goff is chief commercial officer of Viatris, which she joined in April 2024. Her career spans biotechnology leadership at Imunon and Moderna and regional and global commercial roles at Amgen and Roche.

Last reviewed: Oct 21, 2026

Corinne Le Goff

Chief Commercial Officer
Viatris

Last Reviewed: October 21, 2026

Executive Summary

Corinne Le Goff is chief commercial officer of Viatris, which she joined in April 2024. Her career spans biotechnology leadership at Imunon and Moderna and regional and global commercial roles at Amgen and Roche.

Career Highlights

  • Joined Viatris as chief commercial officer in April 2024.
  • Previously served as president and CEO of Imunon and chief commercial officer of Moderna.
  • Led Amgen’s U.S. and European businesses and Roche’s French affiliate.

Professional Journey

Le Goff’s early pharmaceutical career included leadership assignments at Merck, Sanofi and Pfizer. At Roche, she later led global product strategy for neuroscience and rare diseases and served as president of Roche France. She then spent six years at Amgen, progressing through European regional leadership, global product strategy and commercial innovation, and the U.S. business presidency.

She became chief commercial officer at Moderna, where her work included building capabilities for global COVID-19 vaccine access. Before Viatris, she was president and CEO of Imunon, leading an organizational turnaround and rebranding.

She joined Viatris in April 2024 to lead the global commercial organization. Her remit spans the company’s geographic segments and global commercial functions. The 2026 proxy clarifies that her Longboard Pharmaceuticals board service ended in December 2024 when Lundbeck acquired the company.

Education

  • Doctor of Pharmacy — Paris Descartes University
  • Master of Business Administration — La Sorbonne University